Ignite Creation Date:
2024-05-06 @ 6:02 PM
Last Modification Date:
2024-10-26 @ 2:40 PM
Study NCT ID:
NCT05523440
Status:
RECRUITING
Last Update Posted:
2024-02-15
First Post:
2022-08-29
Brief Title:
Bevacizumab andor Niraparib in Patients With Recurrent Endometrial andor Ovarian Cancer With ARID1A Mutation
Sponsor:
University of Oklahoma
Organization:
University of Oklahoma
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-02-15
Start Date Type:
ACTUAL
Primary Completion Date:
2026-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-08-29
First Submit QC Date:
August 29 2022
Study First Post Date:
2022-08-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-13
Last Update Post Date:
2024-02-15
Last Update Post Date Type:
ACTUAL